Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04190979 Completed - Acute Kidney Injury Clinical Trials

Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)

ACCESS
Start date: March 17, 2018
Phase: N/A
Study type: Interventional

Pre-market, single-arm, prospective, open-label, multi-center clinical trial aimed at assessing the safety and the performance of the Medyria TrackCath system in patients undergoing endovascular intervention.

NCT ID: NCT04190680 Completed - Clinical trials for Fruit and Vegetable Consumption in Children

Kokkerelli Learning Street Effect Evaluation

Start date: March 15, 2020
Phase: N/A
Study type: Interventional

In 2012, the Kids University for Cooking Foundation BV has developed a nutrition education programme called 'Kokkerelli Learning Street'. This innovative programme aims to teach primary school students from study years 5-8 where food comes from, how it is processed, and how it can be used for the preparation of a healthy meal. The Kokkerelli Learning Street is offered to primary school children in the region of Venlo, the Netherlands. The present study will investigate the effects of the Kokkerelli Learning Street on several determinants of children's fruit and vegetable intake. Based on the literature and the aims of the Learning Street, five relevant determinants are selected: (i) knowledge; (ii) taste preferences; (iii) intention; (iv) skills; and (v) attitude. Using child-reported questionnaires, the present study aims to answer the following key questions: What are the short-term and longer-term effects of the Kokkerelli Learning Street on children's: - Knowledge regarding fruit and vegetable consumption? - Intentions regarding fruit and vegetable consumption? - Attitude regarding fruit and vegetable consumption? - Liking of fruit and vegetables? - Skills regarding fruit and vegetable preparation? - Fruit and vegetable intake?

NCT ID: NCT04189588 Completed - Clinical trials for Oncology Patients Receiving Chemotherapy

Phase 2 Study IV QUZYTTIRâ„¢ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

versus
Start date: March 25, 2020
Phase: Phase 2
Study type: Interventional

This study is designed to compare the number of infusion reactions to treatment with an anti-CD20 such as Rituxan® (rituximab) or Taxol® (Paclitaxel) after premedication with intravenous (IV) QUZYTTIRâ„¢ cetirizine hydrochloride (HCl) or IV diphenhydramine during first-cycle infusion or re-treatment with an anti-CD20 such as Rituxan® (rituximab) or Paclitaxel. Re-treatment is defined as re-treatment with an anti-CD20 such as Rituxan® (rituximab) or Paclitaxel after 6 months or in patients with persistent infusion reactions while on maintenance or retreatment.

NCT ID: NCT04189003 Completed - Clinical trials for Oropharyngeal Cancer

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

OROPAP
Start date: June 1, 2019
Phase:
Study type: Observational

The aim of this study is to identify HPV molecular signature in head and neck cancer to establish a new classification for positive human papillomavirus oropharyngeal tumor

NCT ID: NCT04188860 Completed - Immunotherapy Clinical Trials

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Start date: December 6, 2019
Phase: Phase 2
Study type: Interventional

For recurrent or persistent advanced cervical cancer patients, the first-line chemotherapy was based on platinum. However, if they were refractory to platinum-based chemotherapy, there were no other more effective medications or treatment. The marketing of anti-PD-1 antibody has provided an opportunity of curative management. This single arm, open, phase II trial would recruit 34 eligible patients. A combination of anti-PD-1 antibody camrelizumab and albumin-bound paclitaxel would be given for first 9 patients. If at least total 2 patients achieved complete or partial remission, or at least total 6 patients achieved complete or partial remission or stable disease, the same regimen would be given for rest patients. The primary end is overall response rate (ORR). The second ends include progression-free survival, overall survival, disease control rate, remission duration, and adverse events. A molecular testing, mainly consisting of genomic analysis, will be carried in the oncologic tissues.

NCT ID: NCT04188847 Completed - Chemotherapy Clinical Trials

First-line Chemotherapy for Recurrent Cervical Cancer

Start date: December 6, 2019
Phase: Phase 2
Study type: Interventional

The response rate of traditional first-line chemotherapy for recurrent or persistent advanced cervical cancer was low. This single arm, open, phase II trial would recruit 37 eligible patients. A combination of cisplatin, paclitaxel and apatinib would be given for first 23 patients. If at least 13 patients achieved complete or partial remission, the same regimen would be given for rest patients. The primary end is overall response rate (ORR). The second ends include progression-free survival, overall survival, disease control rate, remission duration, and adverse events. A molecular testing, mainly consisting of genomic analysis, will be carried in the oncologic tissues.

NCT ID: NCT04188704 Completed - Clinical trials for Anterior Cruciate Ligament Injuries

Comparative Study of the Inclination Angle and Complications of Eccentric Grafts Position in ACL Reconstruction and Normal ACL: Retrospective Cohort

Start date: January 1, 2013
Phase: N/A
Study type: Interventional

The anatomic ACL reconstruction aims at functional restoration of the ACL to its native dimensions, collagen orientation and insertion sites. Even if the anatomic foot prints are correctly chosen for the tibial and femoral tunnels does the position of interference screw in the tibial tunnel alter the ACL orientation? The study hypothesized that the position of interference screw in the tibial tunnel would alter the graft orientation in anatomic ACL reconstruction. The purpose of this study was to compare graft orientation and inclination angle with posterolateral and anteromedial interference screw position in tibial tunnel in aperture fixation techniques.

NCT ID: NCT04188444 Completed - Sterility, Female Clinical Trials

Prothrombotic Biomarkers and Ovarian Stimulation

HEMOSTIM
Start date: March 1, 2017
Phase:
Study type: Observational

The aim of this study is to assess the impact of different protocols used for ovarian stimulation during in vitro fertilization procedures (IVF) on prothrombotic biomarkers (blood coagulation markers associated with thromboembolic events) in the units of reproductive medicine in two university hospitals (HUG, Geneva and CHUV, Lausanne).

NCT ID: NCT04187833 Completed - Clinical trials for Metastatic or Unresectable Melanoma

Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes

Start date: June 5, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate how effective the study drugs, nivolumab (also known as Opdivo®) and talazoparib (also known as Talzenna®) are when given as a combination treatment for unresectable or metastatic melanoma. The study team wants to know the effectiveness of these drugs together in treating cancer than if each study drug was given by itself.

NCT ID: NCT04187768 Completed - Healthy Clinical Trials

Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer

Start date: November 26, 2019
Phase:
Study type: Observational

This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with non small cell lung cancer